[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivani Medical Inc (VANI)

Vivani Medical Inc (VANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,280
  • Shares Outstanding, K 86,235
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,610 K
  • EBIT $ -28 M
  • EBITDA $ -27 M
  • 60-Month Beta 2.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.05

Options Overview Details

View History
  • Implied Volatility 183.41% (+27.66%)
  • Historical Volatility 79.14%
  • IV Percentile 25%
  • IV Rank 14.74%
  • IV High 692.63% on 12/11/25
  • IV Low 95.36% on 08/13/25
  • Expected Move (DTE 5) 0.4675 (34.38%)
  • Put/Call Vol Ratio 6.00
  • Today's Volume 147
  • Volume Avg (30-Day) 84
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 3,206
  • Open Int (30-Day) 2,567
  • Expected Range 0.8925 to 1.8275

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.08
  • Number of Estimates 1
  • High Estimate $-0.08
  • Low Estimate $-0.08
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +23.64%
on 06/15/26
1.6607 -18.11%
on 07/09/26
+0.2300 (+20.35%)
since 06/10/26
3-Month
1.0200 +33.33%
on 04/13/26
1.6607 -18.11%
on 07/09/26
+0.3200 (+30.77%)
since 04/10/26
52-Week
0.9228 +47.38%
on 03/30/26
1.9200 -29.17%
on 10/21/25
+0.0900 (+7.09%)
since 07/10/25

Most Recent Stories

More News
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

ALAMEDA, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, biopharmaceutical company developing novel, ultra long-acting...

VANI : 1.3600 (-12.82%)
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company’s name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent)...

CLRO : 8.39 (-13.06%)
VANI : 1.3600 (-12.82%)
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

FDMT : 12.31 (-4.50%)
VANI : 1.3600 (-12.82%)
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

ALAMEDA, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.3600 (-12.82%)
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

ALAMEDA, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra...

VANI : 1.3600 (-12.82%)
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

ALAMEDA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra...

VANI : 1.3600 (-12.82%)
Vivani Medical: Q1 Earnings Snapshot

Vivani Medical: Q1 Earnings Snapshot

VANI : 1.3600 (-12.82%)
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents,...

VANI : 1.3600 (-12.82%)
Vivani Medical: Q4 Earnings Snapshot

Vivani Medical: Q4 Earnings Snapshot

VANI : 1.3600 (-12.82%)
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under...

VANI : 1.3600 (-12.82%)

Business Summary

Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second...

See More

Key Turning Points

3rd Resistance Point 1.7133
2nd Resistance Point 1.6267
1st Resistance Point 1.4933
Last Price 1.3600
1st Support Level 1.2733
2nd Support Level 1.1867
3rd Support Level 1.0533

See More

52-Week High 1.9200
Fibonacci 61.8% 1.5391
Fibonacci 50% 1.4214
Last Price 1.3600
Fibonacci 38.2% 1.3037
52-Week Low 0.9228

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.